Quotes 5-day view Delayed Nyse
10/26/2020
10/27/2020
10/28/2020
10/29/2020
10/30/2020
Date
482.43(c)
489.3(c)
476.71(c)
471.88(c)
473.12(c)
Last
1 310 888
1 332 107
1 673 269
1 330 140
1 242 269
Volume
+0.47% +1.42% -2.57% -1.01% +0.26% Change
Sales 2020
30 615 M - -
Net income 2020
5 799 M - -
Net Debt 2020
12 098 M - -
P/E ratio 2020
32,4x
Yield 2020
0,18%
Sales 2021
32 500 M - -
Net income 2021
6 253 M - -
Net Debt 2021
6 883 M - -
P/E ratio 2021
29,9x
Yield 2021
0,20%
Capitalization
187 B 187 B -
EV / Sales 2020
6,49x
EV / Sales 2021
5,96x
Nbr of Employees
75 000
Free-Float
90,6%
Thermo Fisher Scientific specializes in the design, manufacturing and marketing of laboratory and scientific equipments. Net sales (including intragroup) break down by family of products as follows:
- laboratory equipments (65.4%). Moreover, the group proposes chemical products (acid, solvent, salts, etc.), consumable products (tubes, funnels, vials, etc.), as well as conditioning, warehousing, storage, etc.;
-...
Notations Surperformance© of Thermo Fisher Scientific
Trading Rating : Investor Rating :
All news about THERMO FISHER SCIENTIFIC
News in other languages on THERMO FISHER SCIENTIFIC
THERMO FISHER SCIENTIFIC - 10/23
The trend should regain control
BUY
Thermo Fisher ends deal agreement for genetic testing firm Qiagen
Chart THERMO FISHER SCIENTIFIC
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends THERMO FISHER SCIENTIFIC
Short Term Mid-Term Long Term Trends Bullish Bullish Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
BUY
Number of Analysts
21
Average target price
501,65 $
Last Close Price
473,12 $
Spread / Highest target
16,2%
Spread / Average Target
6,03%
Spread / Lowest Target
-18,8%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
